Skip to content
healthcare.dev

Breathe

NDC 43742-1263, Argentum Nitricum, Natrum Muriaticum, Sulphur, Aconitum Napellus, Arsenicum Album, Rhus Tox, Adenosinum Cyclophosphoricum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Lung (Suis), Mucosa Nasalis Suis, Pantothenic Acid, Sarcolacticum Acidum, Acetylcholine Chloride, Coumarinum, Malvin, Dysentery Bacillus, Proteus (Morgani), liquid, from Deseret Biologicals, Inc.

Product NDC
43742-1263
Status
Listed
Labeler
Deseret Biologicals, Inc
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43742-1263 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SILVER NITRATE6 [hp_X]/mL
  • SODIUM CHLORIDE6 [hp_X]/mL
  • SULFUR6 [hp_X]/mL
  • ACONITUM NAPELLUS8 [hp_X]/mL
  • ARSENIC TRIOXIDE8 [hp_X]/mL
  • TOXICODENDRON PUBESCENS LEAF8 [hp_X]/mL
  • ADENOSINE CYCLIC PHOSPHATE10 [hp_X]/mL
  • SUS SCROFA UMBILICAL CORD10 [hp_X]/mL
  • SUS SCROFA ADRENAL GLAND10 [hp_X]/mL
  • SUS SCROFA LUNG10 [hp_X]/mL
  • SUS SCROFA NASAL MUCOSA10 [hp_X]/mL
  • PANTOTHENIC ACID10 [hp_X]/mL
  • LACTIC ACID, L-10 [hp_X]/mL
  • ACETYLCHOLINE CHLORIDE6 [hp_C]/mL
  • COUMARIN6 [hp_C]/mL
  • MALVIN15 [hp_C]/mL
  • SHIGELLA DYSENTERIAE30 [hp_C]/mL
  • PROTEUS MORGANII30 [hp_C]/mL

Pharmacologic classes

Cholinergic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]

Package NDCNDC-11Package
43742-1263-14374212630130 mL in 1 BOTTLE, DROPPER (43742-1263-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 43742-1263 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43742-1263 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43742-1263. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.